Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
Gough, Stephen C L, Prof, Bode, Bruce, MD, Woo, Vincent, MD, Rodbard, Helena W, MD, Linjawi, Sultan, MD, Poulsen, Pernille, MD, Damgaard, Lars H, PhD, Buse, John B, Prof
Published in The lancet. Diabetes & endocrinology (01.11.2014)
Published in The lancet. Diabetes & endocrinology (01.11.2014)
Get full text
Journal Article